Augmedix, Inc. (AUGX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	8-K	10-K	10-K	10-K/A	S-1
Revenues	30.9	22.2	16.5	14.1	10.8
Revenue growth	39.6%	34.5%	16.8%	30.4%
Cost of goods sold	17.0	12.2	9.7	9.4	10.0
Gross profit	14.0	10.0	6.8	4.7	0.8
Gross margin	45.1%	45.1%	41.2%	33.2%	7.3%
Selling, general and administrative [+]	26.2	21.3	16.0	14.4	16.7
Sales and marketing	9.3	7.5	4.4	3.6	3.6
General and administrative	16.9	13.8	11.6	10.9	13.2
Research and development	10.1	6.7	4.5	7.0	7.0
EBITDA [+]		-17.2	-12.8	-15.8	-21.3
EBITDA growth	29.7%	34.5%	-18.8%	-26.0%
EBITDA margin	-72.3%	-77.8%	-77.8%	-112.0%	-197.3%
Depreciation and amortization		0.7	0.9	0.9	1.6
EBIT [+]	-22.4	-17.9	-13.7	-16.7	-22.9
EBIT growth	24.7%	31.0%	-18.2%	-27.0%
EBIT margin	-72.3%	-80.9%	-83.1%	-118.7%	-211.9%
Interest expense, net [+]		2.5	1.4	2.8	2.1
Interest expense		2.5	1.5	2.8	2.1
Interest income		0.0	0.0	0.0	0.0
Other income (expense), net [+]	-2.1	2.6	-0.5	1.1	0.8
Gain (loss) on foreign currency transactions		2.2
Other	-2.1	0.4	-0.5	1.1	-0.8
Pre-tax income	-24.4	-17.9	-15.6	-18.5	-24.2
Income taxes	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-24.4	-17.9	-15.6	-18.5	-24.2
Net margin	-79.0%	-80.5%	-94.7%	-131.1%	-223.4%

Basic EPS [+]		($1.91)	($2.22)	($22.24)	($20.32)
Growth		-13.8%	-90.0%	9.5%
Diluted EPS [+]		($0.62)	($2.17)	($0.92)	($20.32)
Growth		-71.5%	135.4%	-95.5%

Shares outstanding (basic) [+]		9.3	7.0	0.8	1.2
Growth		32.7%	745.8%	-30.1%
Shares outstanding (diluted) [+]		28.9	7.2	20.1	1.2
Growth		301.4%	-64.2%	1590.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.